Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2022 09:00 ET | Source: AGC Biologics

Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate

Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
March 24, 2022 08:15 ET | Source: ProPhase Labs, Inc.

ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time

GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract...
March 24, 2022 06:38 ET | Source: Research and Markets

Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Outlook Report 2022: Growing Need for High Potency Active Pharmaceutical Ingredients (HPAPI) - Forecast to 2030

Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Outlook 2020-2030" report has been added to...
March 21, 2022 07:00 ET | Source: Recro Pharma, Inc.

Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation

With Expanded Industry Expertise, Enhanced Service Offerings and Bi-Coastal Operations, Company Now Optimally Positioned to Support Customers’ Goal of Delivering Impactful Medicines to SocietyNew...
March 16, 2022 16:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum

TUSTIN, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
March 08, 2022 16:09 ET | Source: Avid Bioservices, Inc

Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments

-- Recorded Third Quarter Revenue of $31.5 Million -- -- Myford South and Viral Vector Facilities Construction Continues On Schedule -- -- Signed $52 Million in Net New Business Orders and Ended the...
March 01, 2022 16:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022

TUSTIN, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
March 01, 2022 16:05 ET | Source: Recro Pharma, Inc.

Recro Reports Fourth Quarter and Year End 2021 Financial Results

Recorded Q4 Revenue of $22.3 Million; Full Year Revenue of $75.4 Million More than Tripled Customer Base in 2021; Significantly Diversified Clientele Grew Organic New Business by 63% in 2021; Grew...
February 23, 2022 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility

SAN DIEGO, Calif. and GAINESVILLE, Ga., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to...
February 22, 2022 16:05 ET | Source: Recro Pharma, Inc.

Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022

SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving...